Annual Drug Patent Expirations for ALOXI
Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are thirteen patents protecting this drug.
Drug patent litigation for ALOXI.
The generic ingredient in ALOXI is palonosetron hydrochloride. One supplier is listed for this compound. Additional details are available on the palonosetron hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
